FdaApplication
ANDA 217517
Identifiers
- fda_app_no: ANDA217517
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2023-10-19 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PAZOPANIB HYDROCHLORIDE | PAZOPANIB HYDROCHLORIDE | EQ 200MG BASE | TABLET;ORAL |
1 product